Comparison between oxaliplatin therapy and capecitabine monotherapy for high-risk stage II – III elderly patients with colon cancer

Summary: Purpose: 45% of colon cancer patients are elderly, yet they are often deviated from standard cancer management. The MOSAIC trial favored FOLFOX over FL with superior oncologic outcomes; however, which regimen is most beneficial in elderly population remains unclear. This study aimed to com...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jueun Park, HyungJoo Baik, Sang Hyun Kang, Sang Hyuk Seo, Kwang Hee Kim, Min Kyung Oh, Hong Sub Lee, Sang Heon Lee, Ki Hyang Kim, Min Sung An
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2022-01-01
Serie:	Asian Journal of Surgery
Soggetti:	Geriatric patients Colon cancer Adjuvant chemotherapy
Accesso online:	http://www.sciencedirect.com/science/article/pii/S101595842100484X
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!